Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
17 mars 2025 08h00 HE
|
Curevo Vaccine
Curevo Vaccine closes a $110 million Series B round led by Medicxi, with new investors OrbiMed, HBM Healthcare Investments, and Sanofi Ventures.
Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO
10 mars 2025 12h40 HE
|
Tevogen Bio Inc
Vaccine is intended to stimulate T cell responses against targets across the entire genome of the selected virus, similar to company’s lead product candidate TVGN 489, to mitigate the risk posed by...
A Statement from the Global Virus Network (GVN) on the Rise of Measles Cases in the U.S. and Global Implications
25 févr. 2025 15h05 HE
|
Global Virus Network
The GVN urgently recommends the measles-mumps-rubella (MMR) vaccine for unvaccinated children and adults to prevent avoidable and unnecessary health crises
Boehringer Ingelheim launches new trivalent poultry vaccine, includes protection against H5 avian influenza
24 févr. 2025 04h30 HE
|
Boehringer Ingelheim Limited
VAXXITEK® HVT+IBD+H5 is a new trivalent vaccine for poultry that offers protection against Marek’s disease, Infectious Bursal Disease and H5 avian influenza in just one shot. H5 avian influenza...
Vaccine Adjuvants Market to Reach $1.3 billion, Globally, by 2035 at 3.9% CAGR: Allied Market Research
16 févr. 2025 18h30 HE
|
Allied Market Research INC
Wilmington, Delaware, Feb. 16, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Vaccine Adjuvants Market by Type (Immunostimulants, Vehicles and Mucosal Adjuvants),...
Vaccine Technologies Market to Reach $90.6 billion, Globally, by 2033 at 6.4% CAGR: Allied Market Research
10 févr. 2025 09h31 HE
|
Allied Market Research INC
Wilmington, Delaware, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Vaccine Technologies Market by Technology (Live Attenuated Vaccines, Inactivated Vaccines,...
Viral Vaccines Market Size is Projected to Reach USD 93.42 Billion by 2033, Growing at a CAGR of 8.4%: Straits Research
03 févr. 2025 09h19 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Viruses including influenza, mumps, measles, and hepatitis can be among the world's deadliest killers. Researchers from all around the...
Ocugen, Inc. Announces Investigational New Drug Application in Effect After Review by FDA to Initiate Phase 1 Clinical Trial Evaluating First-in-Class OCU500 Inhaled Vaccine Candidate for COVID-19
27 janv. 2025 06h30 HE
|
Ocugen
OCU500 will be administered via inhalation and as a nasal sprayCOVID-19 remains a substantial public health threat in the U.S. and around the worldPhase 1 clinical trial is anticipated to start in 2Q...
Curevo Announces Positive Updated Phase 2 Data for Amezosvatein Shingles Vaccine
12 janv. 2025 10h00 HE
|
Curevo Vaccine
Updated Phase 2 data one year after the second vaccine dose, the anti-gE antibody immune response to amezosvatein continues to be non-inferior to Shingrix
Curevo Vaccine to present at the 43rd Annual J.P. Morgan Healthcare Conference
08 janv. 2025 11h30 HE
|
Curevo Vaccine
Curevo Vaccine will present at the 2025 JPM Healthcare Conference on Wednesday January 15th.